Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
29.27
-0.35 (-1.18%)
Dec 3, 2024, 12:23 PM EST - Market open

Artivion Revenue

Artivion had revenue of $95.78M in the quarter ending September 30, 2024, with 9.02% growth. This brings the company's revenue in the last twelve months to $384.90M, up 13.29% year-over-year. In the year 2023, Artivion had annual revenue of $354.00M with 12.82% growth.

Revenue (ttm)
$384.90M
Revenue Growth
+13.29%
P/S Ratio
3.19
Revenue / Employee
$256,599
Employees
1,500
Market Cap
1.23B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023354.00M40.22M12.82%
Dec 31, 2022313.79M14.95M5.00%
Dec 31, 2021298.84M45.61M18.01%
Dec 31, 2020253.23M-23.00M-8.32%
Dec 31, 2019276.22M13.38M5.09%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pediatrix Medical Group 2.01B
Embecta 1.12B
Tilray Brands 812.04M
Phreesia 389.96M
Innoviva 352.75M
Aurinia Pharmaceuticals 220.36M
Establishment Labs Holdings 153.07M
BioLife Solutions 146.96M
Revenue Rankings